Recently, while attending the 3rd Annual Innovative Approaches to Brain Tumor Management at the Seattle Science Foundation & Swedish Neuroscience Institute/Ivy Center for Advanced Brain Tumor Treatment, our EBCI Patient Services & Support Staff were once again reminded of the amazing contributions the members of our Medical Advisory Board make every single day in improving patient outcomes, advancing science and moving us ever-closer to a Cure.
Dr. Berger’s topic was Brain Tumor Surgical Advances, and he spoke about the importance of functional mapping during surgery for getting as much of the tumor tissue and disease as possible while preserving cognitive function. It was clear that Dr. Berger sees surgery as being both an art and a science. His vision is for brain cancer to become a manageable, chronic disease.
Says Dellann Elliott Mydland, EBCI Founder & President, of Dr. Berger: “Dr. Berger’s work and surgical skills are impressive. I’ve often said had if I or my loved one needed a brain tumor removed, he would be the one to do it. Clinical outcomes show that a brain cancer patient’s very first resection/surgery as well as the ability to safely remove as much of the brain tumor tissue as possible have a direct correlation to the patient’s outcome and survival. Mapping of the brain prior to a brain tumor resection is critical and all patients should demand this practice from their neurosurgeon. If your neurosurgeon does not offer this procedure prior to surgery, you need to opt for another neurosurgeon who does. Contact us at EndBrainCancer.org so that we can connect you to a neurosurgeon who does brain mapping prior to surgery, or simply schedule your surgery with Dr. Berger. We cannot thank Dr. Berger enough for the extra care and steps and improved outcomes he provides to patients via brain mapping.”
Tina Emerson-Hoffman, EBCI Patient Liaison adds: “In listening to Dr. Berger, I was left with a sense of awe at how forward-thinking he is and how it’s all about the patient. He is everything a brain tumor surgeon should be.”
Dr. Berger credits his mentor, the late Charles Wilson, MD, a world-renowned neurosurgeon and UC San Francisco professor emeritus with shaping his life and career. Dr. Wilson recently died at the age of 88, following an illustrious career which included serving as chair of University of California (UCSF) Department of Neurological Surgery for nearly 30 years and founding the University’s Brain Tumor Research Center.
Dr. Berger had this to say of Dr. Wilson, with whom he had worked closely at UCSF as a trainee and later as a colleague.
Two recent journal articles include:
- Berger MS, Hervey-Jumper S, Wick W. Astrocytic gliomas WHO grades II and III. Handb Clin Neurol. 2016;134:345-60. doi: 10.1016/B978-0-12-802997-8.00021-9. PubMed PMID: 26948365.
- Jalbert LE, Neill E, Phillips JJ, Lupo JM, Olson MP, Molinaro AM, Berger MS, Chang SM, Nelson SJ. Magnetic resonance analysis of malignant transformation in recurrent glioma. Neuro Oncol. 2016 Feb 23. pii: now008. [Epub ahead of print] PubMed PMID: 26911151. We salute you, Dr. Berger!